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Relationship of plasma interleukin-6 and its genetic variants with hypertension in 
Hong Kong Chinese
KL Ong, AWK Tso, RYH Leung, SS Cherny, PC Sham, BMY Cheung, KSL Lam
Department of Medicine, The University of Hong Kong, Hong Kong
Introduction: Interleukin-6 (IL-6) is a pro-inflammatory cytokine, which plays a central role in insulin resistance, 
atherogenesis, and hepatic production of acute phase proteins, such as C-reactive protein and fibrinogen. We 
investigated the relationship between plasma IL-6, its genetics variants and hypertension.
Methods: Four tagging single nucleotide polymorphisms (SNPs) were genotyped in 1936 subjects from the 
Hong Kong Cardiovascular Risk Factor Prevalence Study–2 with a median follow-up of 6.4 years. Plasma IL-6 was 
measured using a high-sensitivity enzyme-linked immunosorbent assay (ELISA) in 942 subjects at follow-up. 
Results: After genotyping, the SNP rs2069852 showed significant deviation from the Hardy-Weinberg 
equilibrium (P<0.001) and was excluded from all subsequent analysis. In stepwise multiple linear regression, 
the SNP rs1800796 was independently associated with plasma IL-6 level (beta= –0.098, P=0.002). High IL-6 levels 
were observed in subjects with hypertension (P=0.024), obesity (P=0.023), and the metabolic syndrome (P=0.009) 
after adjusting for age and sex. However, IL-6 was only independently associated with hypertension in women 
(P=0.002) after adjusting for other covariates. Although none of the SNPs showed significant association with 
prevalent hypertension, SNP rs2069837 was significantly associated with lower odds of incident hypertension 
(OR=0.66; 95% CI, 0.47-0.94; P=0.020). The two other SNPs, rs17147230 (OR=0.69; 95% CI, 0.48-0.99, P=0.044) and 
rs1800796 (OR=0.63; 95% CI, 0.39-1.00, P=0.048) also showed nominal association with lower odds of incident 
hypertension in women, but not men.
Conclusion: The inflammation marker, IL-6, appears to play an important role in hypertension, especially in 
women, in our population.
Acknowledgement: This study was funded by Hong Kong Research Grant Council grants (HKU7229/01M and HKU7626/07M), 
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Relationship of genetic variants in gene encoding adrenomedullin with hypertension and 
dysglycaemia in Hong Kong Chinese
KL Ong, AWK Tso, RYH Leung, SS Cherny, PC Sham, BMY Cheung, KSL Lam
Department of Medicine, The University of Hong Kong, Hong Kong
Introduction: Adrenomedullin (AM) is a vasodilatory peptide. It facilitates adipocyte differentiation and affects 
lipolysis and glucose uptake. Therefore, we investigated the association of common genetic variants in the 
adrenomedullin gene (ADM) with elevated blood pressure and dysglycaemia in the Hong Kong Chinese 
population.
Methods: Four single nucleotide polymorphisms (SNPs) in the ADM gene were genotyped in 1936 subjects 
from the Hong Kong Cardiovascular Risk Factor Prevalence Study–2, which has a median follow-up of 6.4 years. 
Elevated blood pressure was defined as blood pressure ≥130/85 mm Hg or taking drug treatment. Dysglycaemia 
included impaired fasting glucose (≥5.6 mmol/L), impaired glucose tolerance (2h glucose ≥7.8 mmol/L) or 
diabetes. 
Results: The minor T allele of SNP rs4910118 was significantly associated with lower systolic blood pressure 
(β= –0.057, P=0.0079) at baseline, but not at follow-up. However, none of the SNPs was significantly associated 
with prevalent or incident hypertension or elevated blood pressure. Although none of the SNPs was 
significantly associated with prevalent dysglycaemia at baseline, the SNP rs11042725 was significantly associated 
with prevalent dysglycaemia at follow-up (OR=1.24; 95% CI, 1.06-1.46; P=0.0093). Among subjects without 
dysglycaemia at baseline, the SNP rs11042725 was a significant predictor of incident dysglycaemia in women at 
follow-up (hazard ratio=1.46; 95% CI, 1.15-1.86; P=0.002), but not in men, using forward stepwise Cox regression 
analysis.
Conclusion: Our study suggests a stronger role of genetic variants in the ADM gene in the development 
of dysglycaemia than that of hypertension in our local Chinese population. Further studies on the genetic 
association of AM with dysglycaemia are warranted.
Acknowledgements: This study was funded by Hong Kong Research Grant Council grants (HKU7229/01M and HKU7626/
07M), and the Sun Chieh Yeh Heart Foundation.
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